Incorporation of Finasteride-Loaded Microspheres into Personalized Microneedle for Sustained Transdermal Delivery

Although finasteride (FNS) tablets are considered the most effective drug for the treatment of androgenetic alopecia (AGA), their clinical applications are limited due to the associated side effects including decreased libido, breast enlargement, and liver dysfunction. In this study, we have develop...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Langmuir : the ACS journal of surfaces and colloids. - 1992. - 40(2024), 20 vom: 21. Mai, Seite 10551-10560
1. Verfasser: Luo, Wenzuo (VerfasserIn)
Weitere Verfasser: Zhang, Xingui, Chu, Yingying, Chen, Tiantian, Sun, Huixuan, Liu, Jiadong, Zhang, Guoxing, Fan, Lihong, Xu, Haixing, Zhang, Yue, Yang, Ming
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2024
Zugriff auf das übergeordnete Werk:Langmuir : the ACS journal of surfaces and colloids
Schlagworte:Journal Article
LEADER 01000caa a22002652 4500
001 NLM371992362
003 DE-627
005 20240521234713.0
007 cr uuu---uuuuu
008 240507s2024 xx |||||o 00| ||eng c
024 7 |a 10.1021/acs.langmuir.4c00280  |2 doi 
028 5 2 |a pubmed24n1414.xml 
035 |a (DE-627)NLM371992362 
035 |a (NLM)38710593 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Luo, Wenzuo  |e verfasserin  |4 aut 
245 1 0 |a Incorporation of Finasteride-Loaded Microspheres into Personalized Microneedle for Sustained Transdermal Delivery 
264 1 |c 2024 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 21.05.2024 
500 |a Date Revised 21.05.2024 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Although finasteride (FNS) tablets are considered the most effective drug for the treatment of androgenetic alopecia (AGA), their clinical applications are limited due to the associated side effects including decreased libido, breast enlargement, and liver dysfunction. In this study, we have developed a personalized microneedle (PMN) with a double-layer structure that incorporates FNS-loaded microspheres (MPs) to accommodate irregular skin surfaces. This design enables the sustained release of FNS, thereby reducing potential side effects. The needle body was synthesized with high-strength hyaluronic acid (HA) as the base material substrate. The backing layer utilized methacrylate gelatin (GelMA) with specific toughness, enabling PMN to penetrate the skin while adapting to various skin environments. The length of PMN needles (10 × 10) was approximately 600 μm, with the bottom of the needles measuring about 330 μm × 330 μm. The distance between adjacent tips was around 600 μm, allowing the drug to penetrate the stratum corneum of the skin. The results of the drug release investigation indicated the sustained and regulated release of FNS from PMN, as compared to that of pure FNS and FNS-MPs. Further, the cytotoxicity assay demonstrates that PMS displays good cytocompatibility. Altogether, this mode of administration has immense potential for the development of delivery of other drugs, as well as in the medical field 
650 4 |a Journal Article 
700 1 |a Zhang, Xingui  |e verfasserin  |4 aut 
700 1 |a Chu, Yingying  |e verfasserin  |4 aut 
700 1 |a Chen, Tiantian  |e verfasserin  |4 aut 
700 1 |a Sun, Huixuan  |e verfasserin  |4 aut 
700 1 |a Liu, Jiadong  |e verfasserin  |4 aut 
700 1 |a Zhang, Guoxing  |e verfasserin  |4 aut 
700 1 |a Fan, Lihong  |e verfasserin  |4 aut 
700 1 |a Xu, Haixing  |e verfasserin  |4 aut 
700 1 |a Zhang, Yue  |e verfasserin  |4 aut 
700 1 |a Yang, Ming  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Langmuir : the ACS journal of surfaces and colloids  |d 1992  |g 40(2024), 20 vom: 21. Mai, Seite 10551-10560  |w (DE-627)NLM098181009  |x 1520-5827  |7 nnns 
773 1 8 |g volume:40  |g year:2024  |g number:20  |g day:21  |g month:05  |g pages:10551-10560 
856 4 0 |u http://dx.doi.org/10.1021/acs.langmuir.4c00280  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_22 
912 |a GBV_ILN_350 
912 |a GBV_ILN_721 
951 |a AR 
952 |d 40  |j 2024  |e 20  |b 21  |c 05  |h 10551-10560